The inhibition of CAIX by S4 treatment altered tumor microenvironment, exaggerated DNA damage, increased apoptosis, and thus enhanced radiotherapy efficacy in ESCC. This evidence concerns the gene CA9 and esophageal squamous cell carcinoma.